One-Third of Drugmakers Skipped Medicare Part B Price-Reporting Requirement

by Admin | August 14, 2014 2:21 pm

August 14, 2014—More than a third of drugmakers failed to submit average sales price data to the federal government for one or more of their Medicare Part B drugs during third quarter of 2012, despite being required to do so, the Department of Health and Human Services Office of Inspector General has found. 

---

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Source URL: https://340binformed.org/2014/08/one-third-of-drugmakers-skipped-medicare-part-b-price-reporting-requirement/

---